Moscow, Russia

Sergey V Timofeev

This inventor holds 1 USPTO granted patent. Top assignee: Nitto-Denko Corporation. Active years: 2006.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sergey V Timofeev: Innovator in Chemical Compounds

Introduction

Sergey V Timofeev is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of chemistry, particularly in the development of new chemical compounds. His innovative work has led to the creation of a unique patent that showcases his expertise and creativity.

Latest Patents

Timofeev holds a patent for a series of new chemical compounds, specifically lyotropic liquid crystal systems and materials. The patent details acenaphtho[1,2-b]quinoxaline sulfoderivatives, characterized by a general structural formula. The parameters of the compounds include integers n, m, and z, which define the structure and composition of the compounds. This invention represents a significant advancement in the field of chemical engineering.

Career Highlights

Timofeev is currently associated with Nitto Denko Corporation, where he continues to apply his knowledge and skills in chemical innovation. His work at the company has allowed him to explore various applications of his inventions, contributing to advancements in technology and materials science.

Collaborations

Throughout his career, Timofeev has collaborated with talented individuals such as Tatyana Y Dutova and Alexey Nokel. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Sergey V Timofeev is a distinguished inventor whose work in chemical compounds has made a lasting impact in his field. His patent and collaborations reflect his commitment to innovation and excellence in research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…